-
EdU Cell Proliferation Kit: From S-Phase to RA
2026-09-05
Discover how the EdU Cell Proliferation Kit converts DNA synthesis into a quantitative functional readout for rheumatoid arthritis research. This article connects ARL4C-driven synoviocyte biology with assay design, controls, interpretation, and translational limitations.
-
Omeprazole A2845: Research Protocol and QC Guide
2026-09-04
Omeprazole A2845 provides a defined H+,K+-ATPase inhibitor for controlled studies of gastric acid secretion, proton-pump activity, and antiulcer mechanisms. Its water and ethanol insolubility requires DMSO-based stock preparation, and the material should remain a research reagent rather than a clinical, diagnostic, or therapeutic product.
-
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-04
S Tag Peptide (SKU A6007) provides a soluble 15-amino-acid fusion element for recombinant protein detection, antibody-based capture, and protein solubility improvement. It is suited to genetically encoded N- or C-terminal tags, but not to ethanol-based formulations, standalone ribonuclease activity, or applications that require the tag itself to form a stable structure.
-
RapaLink-1: A Strategic Lens on mTOR Control
2026-09-03
RapaLink-1 offers translational researchers a mechanistic bridge between resistant mTOR signaling in cancer and experimentally induced embryonic dormancy. This article explains how its bivalent design can guide assay selection, model interpretation, and next-stage validation without overstating preclinical evidence.
-
Firefly Luciferase mRNA: Sex-Aware Assays
2026-09-03
Build sensitive reporter workflows with Cap1, 5-moUTP modification, and an optimized poly(A) tail for sustained Firefly Luciferase mRNA expression. A sex-aware design adds interpretive strength to in vitro delivery studies and mouse imaging experiments by separating expression from downstream immune response.
-
BAPTA-AM Workflows for Calcium Signaling
2026-09-02
BAPTA-AM enables controlled intracellular Ca²⁺ buffering for calcium signaling, apoptosis assays, and injury models. Its value is greatest when calcium chelation is paired with orthogonal viability, channel, and PANoptosis readouts rather than interpreted as a single-pathway intervention.
-
Nonselective β-Blockers and HCT Engraftment
2026-09-02
Nishino and colleagues show that nonselective β-adrenergic blockade can impair hematopoietic regeneration after allogeneic hematopoietic cell transplantation, whereas β1-selective blockade had a different profile. By combining mouse transplantation experiments with clinical cohort analyses, the study identifies blocker selectivity, graft type, posttransplant chemotherapy, and cell dose as important variables for engraftment research.
-
Hexetidine (NSC-17764) Assay Workflows
2026-09-01
Build more informative antimicrobial and biofilm experiments with Hexetidine by combining MIC testing, surface-challenge models, and matrix controls. This workflow distinguishes intrinsic killing from activity lost through adsorption, staining compounds, washing, or biofilm maturation.
-
From Reporter Signal to mRNA Delivery Strategy
2026-09-01
A thought-leadership guide to using Firefly Luciferase mRNA as a mechanistic benchmark for cap chemistry, modified nucleotides, poly(A) tail design, delivery-vector performance, and translational decision-making.
-
Sumatriptan Succinate: Mechanism & Research Use
2026-08-31
Sumatriptan Succinate is a 5-HT1 receptor agonist used to study migraine biology, trigeminovascular signaling, and neuroinflammation. Evidence supports 5-HT1B/1D-mediated vasoconstriction and inhibition of CGRP release, while anti-inflammatory effects remain predominantly preclinical.
-
FK866 (APO866): Turning NAD Dependence into Insight
2026-08-31
FK866 (APO866) offers translational researchers a precise way to interrogate NAMPT-dependent NAD metabolism, with particular relevance to hematologic cancer research and acute myeloid leukemia (AML) treatment research. This thought-leadership guide connects its metabolic mechanism and caspase-independent cell death phenotype with emerging evidence that NAD biology also shapes therapy resistance in epithelial ovarian cancer.
-
RapaLink-1: A Third-Generation mTOR Strategy
2026-08-30
RapaLink-1 offers a resistance-aware approach to mTOR research by combining FKBP12 engagement with kinase-site inhibition. This thought-leadership guide connects its oncology evidence with Nature Protocols work showing that pharmacological mTOR inhibition can reversibly induce embryonic dormancy, while distinguishing established findings from translational opportunities.
-
Geneticin: Selection Meets Ferroptosis
2026-08-29
Geneticin, also known as G418 Sulfate, is more than a selection antibiotic. This guide explains how to use its translation-inhibitory pressure without confusing engineered-cell selection with ferroptosis, antiviral, or hepatocellular carcinoma biology.
-
NVP-BGJ398 phosphate Assay Guide
2026-08-28
This scenario-based guide explains how NVP-BGJ398 phosphate, SKU A3673, can improve experimental interpretation in FGFR-dependent viability, proliferation, and cytotoxicity assays. It covers model selection, formulation, dose design, pathway validation, and practical product-reliability checks.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-28
The reference study identifies CD44 as a metabolic dependency in IDH-mutant leukemia, linking adhesion signaling to pentose phosphate pathway activity, NADPH production, and sustained R-2HG synthesis. Its isogenic genetic models and combination experiments provide a rationale for pairing mutant IDH inhibition with CD44-directed strategies while clarifying why suppression of 2-HG alone may not fully eliminate resistant leukemia cells.